AlbertSKhouriMD

Cataract Related, Glaucoma Related

Professor of Ophthalmology, Director of Glaucoma & Director of Ophthalmology Residency at Rutgers New Jersey Medical School with offices in Newark, NJ

Join to view full profile

Dr. Khouri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khouri's full profile

Already have an account?

Office
90 Bergen Street
Doctors Office Center, Suite 6100
Newark, NJ 07103
Phone+1 973-972-2065

Fax+1 973-972-1244

Summary

Dr Khouri is Professor of Ophthalmology at Rutgers University and is an academic glaucoma specialist with offices at the Institute of Ophthalmology and Visual Science at Rutgers New Jersey Medical School in Newark, NJ.
Dr Khouri specializes in the medical, laser and surgical treatments of glaucoma including Micro-Incisional Glaucoma Surgery (MIGS), and cataract surgery.
Dr Khouri directs the glaucoma research laboratory at Rutgers and conducts clinical trials for novel medications, drug delivery systems as well as innovations in imaging and diagnostics in glaucoma and the field of telemedicine and teleglaucoma.
Dr Khouri serves as Director of the Glaucoma Division and Director of Resident Education.

The academic glaucoma practice of NJ

The glaucoma service at Rutgers NJMS offers medical, laser and surgical treatments for glaucoma at the most comprehensive ophthalmic institute in the state.

Rutgers New Jersey Medical School

Professor of Ophthalmology The academic glaucoma practice in NJ

Researchgate

Research, publications and collaborations

Education & Training

Rutgers New Jersey Medical SchoolResidency, Ophthalmology, 2011
U Louisville SOM2011
Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolInternship, Internal Medicine, 2007 - 2008
UMDNJ- New Jersey Medical SchoolFellowship, 2004 - 2007
American University of Beirut Faculty of MedicineClass of 1992

Certifications & Licensure

NJ State Medical License 2011 - 2025
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Castle Connolly Top Doctors Castle Connolly, 2024
NJ Top Doctors NJ Top Doctors, 2017-2024
President, New Jersey Academy of Ophthalmology NJAO, 2022
J DiSepio Award for Glaucoma Research New Jersey Health Foundation, 2016-2022
America’s Best Eye Doctors Newsweek, 2021
Appreciation Award American Glaucoma Society, 2020
Alpha Omega Alpha National AOA Medical Honor Society, 2019
LDP American Academy of Ophthalmology, 2018
American Academy of Ophthalmology Achievement Award American Academy of Ophthalmology, 2018
Faculty Teaching Award Rutgers New Jersey Medical School, 2011, 2018
MAPS Award for Clinician Scientists American Glaucoma Society, 2011
Join now to see all

Clinical Trials

Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery Start of enrollment: 2007 Jul 01
Completed
Phase 4
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension Start of enrollment: 2011 May 01
Completed
Phase 3
Clinical Validation Study of RTVue Features Start of enrollment: 2011 Mar 01
Completed
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension Start of enrollment: 2013 Jan 31
Completed
Phase 3
Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Start of enrollment: 2014 Jul 01
Completed
Phase 3
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension Start of enrollment: 2014 Dec 15
Completed
Phase 3
The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS) Start of enrollment: 2016 Feb 01
Terminated
Not Applicable
Feasibility of Teleglaucoma Versus Conventional Clinical Evaluation for Diagnostic Accuracy and Management Recommendations in Patients With Glaucoma Start of enrollment: 2016 Aug 01
Completed
Not Applicable
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR Start of enrollment: 2019 Mar 27
Enrolling by invitation
Phase 3
Join now to see all

Publications & Presentations

PubMed

63 citations
Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study.
Albert S Khouri, Janet B. Serle, Jason Bacharach, Dale W. Usner, Richard A Lewis
American Journal of Ophthalmology. 2019-08-01
5 citations
The impact of primary repair timing on longitudinal visual outcomes after open globe injury.
Roger K Henry, Albert Bargoud, Sapna Syal, Abanoob Tadrosse, Ibraheem S Shaikh
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2023-04-01
8 citations
Laser Iridoplasty to Treat Iris-occluded XEN Gel Stent.
Abanoob Tadrosse, Albert S Khouri
Journal of Glaucoma. 2020-08-01

Journal Articles

Treating glaucoma in the age of migs and laser
Christopher Kent, Review of Ophthalmology, 4/1/2021
Transforming the glaucoma treatment paradigm: sustained release drug delivery
Khelly Shah, Ophthalmology Management, 3/2021
Novel glaucoma medications: from clinical trials to clinical experience
V Bekerman, A Khouri, Glaucoma Today, 1/2021
Cyclophotocoagulation in Pediatric Glaucoma
Sarangdev Vaidya, Anthony Fam, Albert S Khouri, EyeWiki AAO online, 7/1/2020
Two Unique Glaucoma Drugs Debut
Albert S Khouri, MD, Review of Ophthalmology, 6/12/2018
Tele-Glaucoma: The Next Frontier
Khouri A, Ophthalmology Management, 12/1/2017
Moving Beyond IOP
K Modi, A Khouri, Glaucoma Today, 6/1/2017
Join now to see all

Abstracts/Posters

Once-daily netarsudil 0.02% vs twice-daily timolol maleate 0.5% in ocular hypertension or open-angle glaucoma, the ROCKET-4 study
Albert Khouri, MD, Newark, NJ Jason Bacharach, MD, North Bay Eye Associates, Inc., Petaluma, CA, United States Richard A. Lewis, MD, Sacramento Eye Consultants, Sacram..., American Glaucoma Society, New York, NY, 3/3/2018
Scleral graft melt post tube shunt surgery: grading and identification of risk factors
Xia T, Uppuluri A, Khouri P, NJ Glaucoma Study Group, American Glaucoma Society, NY, NY, 3/3/2018
Discrepancy between optical and ultrasound central corneal thickness in Glaucoma patients
Mendez N, Chandrasekaran S, Szirth B, Khouri A., American Glaucoma Society, NY, NY, 3/2/2018

Lectures

Tele-Glaucoma: Mentoring for Advancement of Physician Scientists
American Glaucoma Society - 3/3/2018
Promoting Autonomy in Resident Surgical Education
Association of University Professors of Ophthalmology - 1/25/2018

Other

An overview of new glaucoma medications
Chiles samaniego, EyeWorld
https://www.eyeworld.org/overview-new-glaucoma-medications
5/5/2020

Authored Content

Waste in Ophthalmology ORsFebruary 2023
Incidental glaucoma screening using teleophthalmologySeptember 2022
More than a drop in the bucketAugust 2022
Choosing MIGS approachesJune 2022
Will AI-analyzed imaging replace glaucoma diagnosis and monitoring by live clinicians?May 2021
Pathways to PracticeOctober 2020
Overview of new glaucoma medicationsMay 2020
New Pharmacotherapeutics for the Treatment of Glaucoma: Targeting the Trabecular MeshworkOctober 2019
Highlights of the 2019 AGS annual meetingJune 2019
The promise of teleglaucomaMarch 2019
Case presentations in medical glaucomaDecember 2018
Join now to see all

Press Mentions

Netarsudil Lowers IOP in Glaucoma, Ocular HypertensionAugust 30th, 2019
Once-Daily Netarsudil Noninferior to Twice-Daily Timolol in Phase 3 StudyAugust 21st, 2019
Distributed with Glaucoma Today and CollaborativeEYEDecember 23rd, 2018
Join now to see all

Grant Support

Bimatoprost Slow Release ImplantAllergan2013–2020
Artificial Intelligence and Robotic Assisted Tele-Ophthalmology in the Detection of Eye DiseaseNew Jersey Health Foundation2018–2019
Telemedicine for GlaucomaNew Jersey Health Foundation2014–2019
Analysis of MIGS outcomesNew World Medical2017–2018
Tele-Glaucoma feasibility and applications in patient careFund for the New Jersey Blind2017–2018

Committees

Subspecialty program committee, American Glaucoma Society 2018 - Present
Wet lab committee, World Glaucoma Association 2015 - Present
Rutgers New Jersey Medical School, Graduate Medical Education 2013 - Present
Member, New Jersey Academy of Ophthalmology 2011 - Present

Research History

Medical Director of Tele-OphthalmologyTele-Glaucoma Laboratory Glaucoma Imaging and Clinical Trial Research Lab2011 - Present

Professional Memberships

American Academy of Ophthalmology - AAO
Member
Association for Research in Vision and Ophthalmology
Member
American Glaucoma Society
Member
Association of University Professors of Ophthalmology
Member
International Society for Glaucoma Surgery
Member
New Jersey Academy of Ophthalmology
Member

External Links

Rutgershttp://njms.rutgers.edu/resource_locator/find_people/profile.cfm?mbmid=khourias
Researchhttps://www.researchgate.net/profile/Albert_Khouri